Towards the construction of a virtual yeast

Nature. 2026 Jul;655(8121):59-70. doi: 10.1038/s41586-026-10574-9. Epub 2026 Jul 1.ABSTRACTTo advance the computational simulation of cellular life, we propose a virtual yeast, an artificial intelligence (AI)-driven agent that models eukaryotic cellular behaviours by integrating multimodal biologica

L Liujia Qian

Weight discrimination and cardiometabolic health in underrepresented US adults

J Behav Med. 2026 Jul 1. doi: 10.1007/s10865-026-00696-w. Online ahead of print.ABSTRACTThis study investigated the association between perceived weight discrimination and cardiometabolic health. A demographically diverse sample of 2632 US adults (36% Black/African American; 36% Hispanic/Latino; 29%

M Mary A Gerend

Targeted Treatment for Hyperuricemia: The Drug Pipeline

Drugs Aging. 2026 Jul 1. doi: 10.1007/s40266-026-01313-w. Online ahead of print.ABSTRACTGout is the most prevalent inflammatory arthritis worldwide and disproportionately affects older adults, who frequently have comorbid conditions such as chronic kidney disease and cardiovascular disease that lead

A Austin Barry

Japanese-Style Diet and LOX-Index in Japanese Municipal Workers

J Nutr Sci Vitaminol (Tokyo). 2026;72(3):212-221. doi: 10.3177/jnsv.72.212.ABSTRACTJapanese-style diet has been reported to be associated with decreased risk of cardiovascular disease. However, no study has examined the association between a Japanese-style diet and LOX-index, which reflects the prog

M Mirai Sakanari

Lipid-lowering for people with chronic kidney disease: a narrative review

Drug Ther Bull. 2026 Jul 1:dtb-2024-000059. doi: 10.1136/dtb.2024.000059. Online ahead of print.ABSTRACTChronic kidney disease (CKD) affects approximately 14% of adults worldwide, and CKD independently contributes to cardiovascular risk. Hereby, we provide a narrative review of cholesterol-lowering

D David J Tunnicliffe

Preclinical human models of primary ciliary dyskinesia

Eur Respir Rev. 2026 Jul 1;35(181):250334. doi: 10.1183/16000617.0334-2025. Print 2026 Jul.ABSTRACTPrimary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder caused by defective motile cilia, resulting in impaired mucociliary clearance, chronic respiratory disease, laterality defects a

J Jonathan W Y Ong

Utilising human cellular models of primary ciliary dyskinesia: a scoping review

Eur Respir Rev. 2026 Jul 1;35(181):250193. doi: 10.1183/16000617.0193-2025. Print 2026 Jul.ABSTRACTBACKGROUND: Primary ciliary dyskinesia (PCD) comprises a group of rare genetic disorders that primarily affect the function of motile respiratory cilia, leading to progressive sinopulmonary disease. Di

J Jonathan W Y Ong